WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)

Clinical trial NCT00153582 · UNKNOWN

Trial details

NCT number: NCT00153582
Sponsor: Charite University, Berlin, Germany
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndrome

Start date: 2002-04-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.